ArticleQuantitative imaging in medicine and surgery2026
Cardiac computed tomography-derived left atrial volume index as a predictor of major adverse cardiovascular events after transcatheter aortic valve replacement.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Left atrial volume index (LAVI) has been recognized as a significant indicator of left heart remodeling and diastolic dysfunction. This study aimed to investigate the association between LAVI assessed by coronary computed tomography angiography (CCTA) and major adverse cardiovascular events (MACEs) in patients with severe aortic stenosis (AS) after transcatheter aortic valve replacement (TAVR). Methods: This retrospective single-center study enrolled patients with severe AS undergoing TAVR between February 2020 and June 2024. All patients underwent CCTA examination prior to TAVR. Left atrial (LA) volume was automatically quantified from CCTA images, and the LAVI was computed by indexing to body surface area (BSA). Univariate and Firth-penalized Cox proportional hazards regression analyses were used to determine the predictors of MACE. Additionally, restricted cubic spline analysis was performed to explore the relationship between LAVI and MACE. Results: A total of 206 patients (113 males, 93 females; mean age 68.11±8.01 years) were included in the final analysis. The incidence of MACE was 13.1% over a median follow-up time of 581 [interquartile range (IQR), 378-990] days. The LAVI was significantly higher in patients with MACE than in those without MACE [70.14 (54.81-84.12) Conclusions: Preprocedural CCTA-derived LAVI may aid risk stratification for MACE after TAVR in severe AS. Male patients warrant closer postprocedural attention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.